Wolverine Asset Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-255,240
Closed -$3.03M 1771
2025
Q1
$3.03M Sell
255,240
-2,014
-0.8% -$23.7K 0.04% 409
2024
Q4
$3M Sell
257,254
-157,767
-38% -$1.83M 0.03% 422
2024
Q3
$4.76M Sell
415,021
-5,802
-1% -$66K 0.05% 306
2024
Q2
$4.74M Buy
420,823
+58,469
+16% +$656K 0.05% 303
2024
Q1
$4.03M Sell
362,354
-101,817
-22% -$1.12M 0.05% 330
2023
Q4
$5.08M Buy
464,171
+104,768
+29% +$1.14M 0.04% 349
2023
Q3
$3.88M Buy
+359,403
New +$3.86M 0.04% 381
2023
Q2
Sell
-41,111
Closed -$431K 1915
2023
Q1
$431K Sell
41,111
-26,202
-39% -$272K 0.01% 892
2022
Q4
$690K Buy
+67,313
New +$683K 0.01% 854

Other funds holding RENE

Wolverine Asset Management's RENE Position: Q2 2025 in Review

Wolverine Asset Management sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 255,240 shares — an estimated $3.03M sold.

Wolverine Asset Management first reported a position in RENE in Q4 2022 and held it in 9 quarters. The position peaked at $5.08M in Q4 2023. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Wolverine Asset Management reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 255,240 Cartesian Growth Corp II shares in Q2 2025, an estimated $3.03M.
  • Wolverine Asset Management first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 9 quarters.
  • Wolverine Asset Management's Cartesian Growth Corp II position peaked at $5.08M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Wolverine Asset Management's 13F filing for Q2 2025, filed 4 Aug 2025.